AIM ImmunoTech AIM Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
Revenue estimate$100.0K
EPS estimate-$0.94
Next report
Aug 13, 2026 (in a month)Revenue estimate$100.0K
EPS estimate-$0.17
Versus estimates
Revenue
Q1 2026$22.0KBeat by $11.0K
Q4 2025$21.0KMiss by $79.0K
Q3 2025$26.0KQ2 2025$25.0KMiss by $75.0KQ1 2025$16.0KQ4 2024$45.0KMiss by $55.0KDiluted EPS
Ask the moment AIM ImmunoTech reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did AIM ImmunoTech report Q4 2025 earnings?
- AIM ImmunoTech (AIM) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were AIM ImmunoTech's Q4 2025 revenue and EPS?
- AIM ImmunoTech reported revenue of $21.0K and diluted EPS of $-0.44 for Q4 2025.
- Did AIM ImmunoTech beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $100.0K by $79.0K. EPS beat the consensus estimate of $-0.94 by $0.50.
- How did AIM ImmunoTech's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 53.3% from $45.0K a year earlier and diluted EPS grew 95.6% from $-10.00.
- Where can I find AIM ImmunoTech's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-013301) directly on SEC EDGAR. The filing index links above go to sec.gov.